Superficial Curettage Plus Imiquimod Cream for Nodular Basal Cell Carcinoma
This secondary analysis of a randomized clinical trial compares the efficacy of superficial curettage followed by imiquimod cream, 5%, with that of surgical excision among patients with nodal basal cell carcinoma at 5-year follow-up.